Eyepoint Pharmaceuticals Inc (EYPT) — Cash Flow Reinvestment Rate
Eyepoint Pharmaceuticals Inc (EYPT) has a Cash Flow Reinvestment Rate of 0.25x as of June 2023, reinvesting $14.26 Million (capex $396.00K plus investments $13.86 Million) from operating cash flow of $57.02 Million. See how much free cash does Eyepoint Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eyepoint Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2023)
Historical reinvestment intensity for Eyepoint Pharmaceuticals Inc across 3 annual periods. For the full cash flow conversion analysis, see Eyepoint Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Eyepoint Pharmaceuticals Inc (2010–2023)
Year-by-year capital reinvestment analysis for Eyepoint Pharmaceuticals Inc. See how financially flexible is Eyepoint Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.63x | $6.80 Million | $1.88 Million | $3.48 Million | ▲ +727.8% |
| 2015 | 0.44x | $4.51 Million | $10.30 Million | $161.00K | ▲ +28804.5% |
| 2010 | 0.00x | $15.00K | $9.90 Million | $15.00K | — |